Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Operating Expenses | 9,142 | 14,572 | 3,137 | 0 | 0 |
| Operating Income | -9,142 | -14,572 | -3,137 | N/A | N/A |
| Other Income | 40 | -2,912 | -6 | 0 | 0 |
| Pre-tax Income | -9,102 | -17,484 | -3,143 | 0 | 0 |
| Income Tax | 1 | -1 | 6 | N/A | N/A |
| Net Income Continuous | -9,103 | -17,483 | -3,149 | N/A | N/A |
| Net Income | $-9,103 | $-17,483 | $-3,149 | $N/A | $N/A |
| EPS Basic Total Ops | -158.38 | -620.94 | -113.39 | N/A | N/A |
| EPS Basic Continuous Ops | -158.70 | -620.70 | -114.36 | N/A | N/A |
| EPS Diluted Total Ops | -158.38 | -620.94 | -113.39 | N/A | N/A |
| EPS Diluted Continuous Ops | -158.70 | -620.70 | -114.36 | N/A | N/A |
| EBITDA(a) | $-9,133 | $-14,568 | $-3,132 | $N/A | $N/A |